Profil
Timothy D.
Hunt is currently the Chief Executive Officer at Alliance for Regenerative Medicine and also serves as the Director at American Society of Gene & Cell Therapy.
He previously worked as the Director-State Government Affairs at BGR Holding LLC, Vice President-Public Affairs at Biogen, Inc., Senior Vice President-Public Affairs at Cubist Pharmaceuticals LLC, and Senior Manager-State Government Relations at GlaxoSmithKline LLC.
He also served as the Senior Vice President-Corporate Affairs at Editas Medicine, Inc. from 2016 to 2020 and as the Chief Culture & Corporate Affairs Officer at Xilio Therapeutics, Inc. from 2021 to 2022.
Mr. Hunt received his undergraduate degree from Boston College and his graduate degree from Columbus School of Law.
Postes actifs de Timothy D. Hunt
| Sociétés | Poste | Début |
|---|---|---|
American Society of Gene & Cell Therapy
American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services Operates as medical and professional organization that represents researchers and scientists devoted to the discovery | Directeur/Membre du Conseil | - |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Directeur Général | 06/09/2022 |
Anciens postes connus de Timothy D. Hunt
| Sociétés | Poste | Fin |
|---|---|---|
| XILIO THERAPEUTICS, INC. | Responsable des Ressources Humaines | 01/08/2022 |
| EDITAS MEDICINE, INC. | Corporate Officer/Principal | 01/03/2020 |
| BIOGEN INC. | Public Communications Contact | 01/01/2011 |
BGR Holding LLC
BGR Holding LLC Miscellaneous Commercial ServicesCommercial Services Provides legal services | Conseiller Juridique Général | - |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Conseiller Juridique Général | - |
Formation de Timothy D. Hunt
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Cubist Pharmaceuticals LLC
Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of pharmaceutical products | Health Technology |
BGR Holding LLC
BGR Holding LLC Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Boston College
Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
Editas Medicine, Inc.
Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines | Health Technology |
Columbus School of Law
Columbus School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Society of Gene & Cell Therapy
American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services Operates as medical and professional organization that represents researchers and scientists devoted to the discovery | Commercial Services |
Xilio Therapeutics, Inc.
Xilio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops tumor-selective immuno-oncology therapies | Health Technology |
















